Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,452,319
Closed -$29.3M 1259
2025
Q2
$29.3M Buy
1,452,319
+1,323,470
+1,027% +$22.9M 0.13% 111
2025
Q1
$1.8M Buy
128,849
+91,156
+242% +$1.26M 0.01% 447
2024
Q4
$447K Sell
37,693
-174,703
-82% -$2.75M ﹤0.01% 725
2024
Q3
$3.81M Buy
+212,396
New +$3.87M 0.02% 349
2024
Q1
Sell
-20
Closed -$521 1258
2023
Q4
$521 Hold
20
﹤0.01% 1000
2023
Q3
$461 Hold
20
﹤0.01% 943
2023
Q2
$474 Hold
20
﹤0.01% 980
2023
Q1
$238 Sell
20
-184
-90% -$2.62K ﹤0.01% 951
2022
Q4
$3.13K Buy
+204
New +$3.57K ﹤0.01% 1028

Other funds holding XP

Natixis's XP Position: Q3 2025 in Review

Natixis sold out of XP (XP) in Q3 2025, closing a stake of 1,452,319 shares — an estimated $29.3M sold.

Natixis first reported a position in XP in Q4 2022 and held it in 9 quarters. The position peaked at $29.3M in Q2 2025. 328 funds tracked by Wall St. Rank hold XP as of Q3 2025.

  • Natixis reported no remaining XP position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 1,452,319 XP shares in Q3 2025, an estimated $29.3M.
  • Natixis first reported a position in XP in Q4 2022 and held it in 9 quarters.
  • Natixis's XP position peaked at $29.3M in Q2 2025.
  • 328 funds tracked by Wall St. Rank held XP as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.